Results 11 to 20 of about 7,701 (203)

The role of L-type amino acid transporter 1 in the pathogenicity of Candida albicans [PDF]

Microbiology Spectrum
Our recent study showed that lat1, which encodes L-type amino acid transporter 1 (Lat1) was centrally positioned in the gene co-expression network of a Candida albicans (C. albicans) infection model of cell culture and suggested that this gene might play
Yibing Lan, Cheng Wu, Peng Du, Jie Jiao, Chunming Li, Ketan Chu, Tao Zhang, Peiqiong Chen, An Li, Wenxian Xu, Xinyi Ying, Jianhong Zhou, Wenlong Lin, Linjuan Ma, Yizhou Huang   +14 more
doaj   +2 more sources

Distinct host immune responses in recurrent vulvovaginal candidiasis and vulvovaginal candidiasis

Frontiers in Immunology, 2022
Recurrent vulvovaginal candidiasis (RVVC) and vulvovaginal candidiasis (RVVC) are one of the most common gynecological infections, primarily caused by Candida species. Although risk factors of RVVC and VVC have been identified in many studies, antifungal
Gai Ge, Zhiya Yang, Dongmei Li, Ning Zhang, Biao Chen, Dongmei Shi, Dongmei Shi   +6 more
doaj   +3 more sources

Fluconazole-resistant vulvovaginal candidiasis in reproductive-age women: a study from Himalayan country [PDF]

BMC Microbiology
Background Vulvovaginal candidiasis is the second most common fungal infections among reproductive-age women. These conditions are commonly treated with the azole derivatives administered locally or systemically, most commonly fluconazole (FCZ).
Deepshikha Yadav, Purnima Baidya, Prabhakar R. Panday, Pritee Yadav, Kul R. Rai, Prasha Shrestha, Manita Aryal   +6 more
doaj   +2 more sources

Combination of antifungal agent and prebiotic for acute vulvovaginal candidiasis [PDF]

РМЖ. Мать и дитя, 2019
Combination of antifungal agent and prebiotic for acute vulvovaginal candidiasis P.N. Krotin, O.V. Kirilenko City Consultative Diagnostic Center “Juventa”, St.
Krotin P.N., Kirilenko O.V.
doaj   +1 more source

Epidemiologic features of Vulvovaginal Candidiasis among reproductive-age women in India. [PDF]

, 2012
BACKGROUND: Vulvovaginal candidiasis is characterized by curd-like vaginal discharge and itching, and is associated with considerable health and economic costs.
Madhivanan, Purnima, Rathod, Sujit, Rhinegold, Arthur R., Krupp, Karl, Klausner, Jeffrey D., Rathod, Sujit D, Reingold, Arthur L, Rathod, Sujit D., Klausner, Jeffrey D, Reingold, Arthur L.   +9 more
core   +3 more sources

Probiotic supplementation during pregnancy for vaginal microbiota improvement and pathogen clearance: A systematic review and meta-analysis. [PDF]

Acta Obstet Gynecol Scand
Probiotic supplementation during pregnancy shows a modest, non‐robust increase in Group B Streptococcus decolonization, with no consistent benefit for bacterial vaginosis or vulvovaginal candidiasis. Probiotics may serve as a non‐antibiotic adjunct, but standardized regimens and ecological diagnostic frameworks are required.
Liu Z, Huang R, Sun T, Zhu L.
europepmc   +2 more sources

Treatment of Recurrent Vulvovaginal Candidiasis With Ibrexafungerp

Journal of Investigative Medicine High Impact Case Reports, 2022
Recurrent vulvovaginal candidiasis is a common disorder which causes significant morbidity among women worldwide, and treatment options are limited.
Leah M. Grant MD, Robert Orenstein DO
doaj   +1 more source

Increased vulvovaginal candidiasis incidence risk in various gestational ages at a private midwifery practice in Surabaya, Indonesia

Majalah Obstetri dan Ginekologi, 2022
HIGHLIGHTS 1. Hormonal changes during pregnancy lead to the presence of vulvovaginal candidiasis. 2. Increased incidence of vulvovaginal candidiasis in different pregnancy trimesters were analyzed. 3.
Regina Martina Cilik, Willy Sandhika, Zakiyatul Faizah   +2 more
doaj   +1 more source

Vulvovaginal Candidiasis [PDF]

Pharmacy Today, 2019
Vulvovaginal candidiasis is the second most common vaginal infection after bacterial vaginosis. It is caused by yeasts, the vast majority of which belong to the genus Candida. Vulvovaginal candidiasis affects as many as 75 % of women during their childbearing years and 40 % of them experience recurrences.
Jill C. Cash, Rhonda Arthur
  +5 more sources

Vulvovaginal candidiasis

Obstetrics and Gynecology Clinics of North America, 2003
VVC represents a spectrum of disease. Although there is a clear need for better use of diagnostic modalities and development of better treatment alternatives, most patients with VVC, even the complicated cases, at least have the perspective of achieving adequate control of their symptoms.
Paul, Nyirjesy, Jack D, Sobel
  +6 more sources